Trials / Active Not Recruiting
Active Not RecruitingNCT07362030
Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin
A Open-Label, Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin in Healthy Participants
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The drug-drug interaction study had been designed to investigate the effect of RAY1225 on the pharmacokinetics of digoxin, Rosuvastatin and
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RAY1225 | subcutaneous injection |
| DRUG | atorvastatin calcium tablet | Oral |
| DRUG | Metformin Tablets | Oral |
| DRUG | Warfarin Sodium Tablets | Oral |
| DRUG | Digoxin Tablets | Oral |
Timeline
- Start date
- 2025-04-14
- Primary completion
- 2025-12-27
- Completion
- 2026-03-30
- First posted
- 2026-01-23
- Last updated
- 2026-01-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07362030. Inclusion in this directory is not an endorsement.